Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zeze Biotech is a specialized pharmaceutical R&D service provider and drug developer headquartered in Shanghai, China. The company focuses on high-end generic drugs and improved new drugs via the 505(b)(2) pathway, offering a full suite of services from pharmaceutical chemistry to clinical bioequivalence. Zeze Biotech is particularly recognized for its expertise in complex formulations, including oral solid dosage forms with modified release profiles and difficult-to-solubilize compounds. By integrating R&D centers in Shanghai and Shandong, the firm accelerates the development of high-quality medicines for both domestic and international markets. Their business model effectively combines contract research services with an internal pipeline of value-added generic products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 则正生物科技.